Overview
PHVS market data
Price History
PHVS price chart · 1M
- O
- 35.87
- H
- 36.31
- L
- 35.23
- C
- 35.24
- Vol
- 35,782.00
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $35.87
- Previous Close
- $35.60
- Day High
- $36.31
- Day Low
- $35.23
- 52 Week High
- $38.06
- 52 Week Low
- $28.38
- 7 Day Return
- -0.27%
- 30 Day Return
- +5.30%
- 90 Day Return
- +11.25%
- 1 Year Return
- +17.62%
- Daily Notional Volume
- $1.3M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$2.97 Diluted earnings per share over the trailing twelve months.
- Beta
- -2.69 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $20.65 – $38.13 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $2.5B · P/B 5.65.
Company News
10 captured
Assessment of AAE-C1INH Disease Burden and Validation of Clinical Trial Endpoints Published in Frontiers in ImmunologyGlobenewswire Inc ·
After a 96% 1-Year Run, This Director Sold 37,600 PHVS Shares for $1.3 Million. Is the Rally Over?The Motley Fool ·